These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 12042878

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sex hormones, neuroprotection and cognition.
    Behl C.
    Prog Brain Res; 2002; 138():135-42. PubMed ID: 12432767
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Melatonin and the aging brain.
    Bondy SC, Sharman EH.
    Neurochem Int; 2007 Mar; 50(4):571-80. PubMed ID: 17276551
    [Abstract] [Full Text] [Related]

  • 5. Membrane-initiated signaling of estrogen in the brain.
    Rønnekleiv OK, Malyala A, Kelly MJ.
    Semin Reprod Med; 2007 May; 25(3):165-77. PubMed ID: 17447206
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane.
    Sheldahl LC, Marriott LK, Bryant DM, Shapiro RA, Dorsa DM.
    Minerva Endocrinol; 2007 Jun; 32(2):87-94. PubMed ID: 17557034
    [Abstract] [Full Text] [Related]

  • 7. Selective estrogen receptor modulators as brain therapeutic agents.
    Arevalo MA, Santos-Galindo M, Lagunas N, Azcoitia I, Garcia-Segura LM.
    J Mol Endocrinol; 2011 Feb; 46(1):R1-9. PubMed ID: 21071476
    [Abstract] [Full Text] [Related]

  • 8. Mitochondrial mechanisms of estrogen neuroprotection.
    Simpkins JW, Dykens JA.
    Brain Res Rev; 2008 Mar; 57(2):421-30. PubMed ID: 17512984
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation.
    Rainey-Smith S, Schroetke LW, Bahia P, Fahmi A, Skilton R, Spencer JP, Rice-Evans C, Rattray M, Williams RJ.
    Neurosci Lett; 2008 Jun 13; 438(1):29-33. PubMed ID: 18467030
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target.
    Arnold S, Beyer C.
    J Neurochem; 2009 Jul 13; 110(1):1-11. PubMed ID: 19457121
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ageing, oestrogen, platelets and thrombotic risk.
    Miller VM, Jayachandran M, Owen WG.
    Clin Exp Pharmacol Physiol; 2007 Aug 13; 34(8):814-21. PubMed ID: 17600564
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. From structural biochemistry to expression profiling: neuroprotective activities of estrogen.
    Manthey D, Behl C.
    Neuroscience; 2006 Aug 13; 138(3):845-50. PubMed ID: 16343783
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways.
    Xia Y, Xing JZ, Krukoff TL.
    Neuroscience; 2009 Aug 18; 162(2):292-306. PubMed ID: 19410635
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of cystatin C prevents oxidative stress-induced death in PC12 cells.
    Nishiyama K, Konishi A, Nishio C, Araki-Yoshida K, Hatanaka H, Kojima M, Ohmiya Y, Yamada M, Koshimizu H.
    Brain Res Bull; 2005 Sep 30; 67(1-2):94-9. PubMed ID: 16140167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.